✦ LIBER ✦

An open-label, noncomparative, dose escalation pilot study of the effect of paroxetine in treatment of burning mouth syndrome

✍ Scribed by Yutaka Yamazaki; Hironobu Hata; Shogo Kitamori; Makiko Onodera; Yoshimasa Kitagawa

Book ID: 116942383
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 380 KB
Volume: 107
Category: Article
ISSN: 1528-395X
DOI: 10.1016/j.tripleo.2008.08.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open-label, dose escalation pilot stu

An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome

✍ Miriam Grushka; Joel Epstein; April Mott 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 496 KB

Gabapentin has little or no effect in th

Gabapentin has little or no effect in the treatment of burning mouth syndrome – results of an open-label pilot study

✍ S. M. Heckmann; J. G. Heckmann; A. Ungethüm; P. Hujoel; T. Hummel 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Fluconazole in the treatment of systemic

Fluconazole in the treatment of systemic candidiasis: an open-label, noncomparative, multinational study

✍ David L. Gibbs 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 426 KB

Duloxetine in the treatment of irritable

Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study

✍ Brian P. Brennan; Kate V. Fogarty; Jacqueline L. Roberts; Karina A. Reynolds; Ha 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## Abstract ## Objective To assess the efficacy of duloxetine for irritable bowel syndrome (IBS). ## Methods We conducted an open‐label 12‐week trial of duloxetine 60 mg daily in 15 patients with IBS without concurrent major depressive disorder. The primary outcome measure was average abdominal

P.2.033 Paroxetine augmentation of neuro

P.2.033 Paroxetine augmentation of neuroleptic treatment in chronic schizophrenia: An open label pilot study

✍ M.C. Jockers-Scherübl; F. Godemann; A. Pietzcker 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Rituximab in the treatment of dermatomyo

Rituximab in the treatment of dermatomyositis: An open-label pilot study

✍ Todd D. Levine 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views